Cardiac Remote Patient Monitoring Devices are Designed to Help Physicians Monitor a Patient's Health Outside The Clinic

Cardiac Remote Patient Monitoring Devices
Cardiac Remote Patient Monitoring Devices


A Cardiac Remote Patient Monitoring Device connects to a patient's home medical equipment via a secure internet portal. The device's wireless communication technology enables the physician to review data anytime, anywhere. This saves the hassle of visiting the doctor every three to six months to download the data. With a cardiac remote monitoring device, the patient only needs to go to the doctor once or twice a year. The remote monitoring of cardiac devices is a new game-changer in medical care. It allows physicians to monitor a patient's health from the comfort of their home. The recent pandemic has reinforced the importance of remote cardiac device monitoring. If properly implemented, the technology can save lives.

Another option is the implantable Cardiac Remote Patient Monitoring Devices Market. They are designed for long-term use and are implanted just under the skin of the patient. Implantable devices are more expensive but allow for more convenient monitoring of patients with chronic heart conditions. Most are worn for three to 30 days. They have built-in functions, such as auto-triggering when the patient experiences symptoms like chest pain. The data recorded by these devices is then transmitted to the healthcare team.

Cardiac Remote Patient Monitoring Device use non-invasive monitoring technologies to detect early symptoms of a heart problem and alert physicians to intervene in the patient's care. As the demand for remote cardiac monitoring grows, so too do the demands on health care infrastructure and compensation structures. In addition to the increasing use of remote patient monitoring, the technology also enables physicians to provide better care to patients suffering from chronic diseases like coronary artery disease and congestive heart failure. Cardiologists can benefit from RPM. Besides improving patient adherence, this technology allows practitioners to track vital patient data in-between visits.

Source Link: https://www.globenewswire.com/news-release/2022/02/08/2381019/0/en/Global-Cardiac-Remote-Patient-Monitoring-Device-Market-to-Surpass-US-680-Million-by-2028-Says-Coherent-Market-Insights-CMI.html

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more